{"lastName":"Draper","objectUrn":"urn:li:member:589645588","geoRegion":"Dallas-Fort Worth Metroplex","fullName":"Christy Draper","firstName":"Christy","currentPositions":[{"companyName":"Southwest Women's Oncology","description":"The Director of Clinical Research will provide oversight, leadership, and guidance in the management and execution of clinical research at Optimum Clinical Research Group and Southwest Women\u2019s Oncology Inc. The Director will work collaboratively with the executive team to oversee start-up of a new research program. He\/She will establish research priorities, operational structure, assess organizational processes and create a research program that influences future health practice through integration of research with clinical care.  The Director\u2019s portfolio includes overseeing research in the performance of oncology clinical trials, establishing a tumor biobank, precision medicine \/ diagnostics trials, cancer control and prevention research, health outcomes & integrative therapies research, women\u2019s health research, community outreach, and working to establish funding strategies for research in regenerative medicine, exercise & environmental medicine, and hyperbarics with the Optimum Human Performance Center. The Director is a leader, team player, problem solver, lifelong learner, and a self-starter. They maintain excellent rapport with all OCRG, SWWO, and Optimum Staff. They will enable and facilitate research while providing the infrastructure to ensure the research is conducted in accordance with all governing laws and regulations.","title":"Executive Director, Clinical Research","companyUrnResolutionResult":{"employeeCountRange":"11-50","headquarters":{"geographicArea":"New Mexico","country":"United States","city":"Albuquerque","postalCode":"87106","line2":"Suite 304","line1":"201 Cedar St SE"},"website":"https:\/\/swwomensoncology.com\/","flagshipCompanyUrl":"https:\/\/www.linkedin.com\/company\/swwomensoncology\/","industry":"Medical Practices"},"companyUrn":"urn:li:fs_salesCompany:68141637","tenureAtCompany":{"numYears":4,"numMonths":2},"startedOn":{"month":4,"year":2020}}],"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)","profilePictureDisplayImage":{"artifacts":[{"width":100,"fileIdentifyingUrlPathSegment":"100_100\/0\/1713315090197?e=1723075200&v=beta&t=kC9xu8AyzYgtwEEgcZyOSl2ht0xGFW2p1ocA1Cn9Jzk","height":100},{"width":200,"fileIdentifyingUrlPathSegment":"200_200\/0\/1713315090197?e=1723075200&v=beta&t=7Sy8CRrsh8VVTbs8f4xM6xIJ_v-jvxDHUlA_rL0IWxk","height":200},{"width":400,"fileIdentifyingUrlPathSegment":"400_400\/0\/1713315090197?e=1723075200&v=beta&t=CIpfnLNjkJJxbKAq40D5fQnMEcverdUZv6FmAc_t0-k","height":400},{"width":800,"fileIdentifyingUrlPathSegment":"800_800\/0\/1713315090197?e=1723075200&v=beta&t=PKdOX6AUVlh8wZXkxkrZoojfFQnstTgy-fni4syny-U","height":800}],"rootUrl":"https:\/\/media.licdn.com\/dms\/image\/D5603AQG1LAmPsxVlmw\/profile-displayphoto-shrink_"},"projects":[{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cA Phase I \/ Randomized Phase II Study of MLN0128 (TAK-228) vs. Pazopanib in Patients with Locally Advanced\/ Unresectable and\/or Metastatic Sarcoma\u201d","startedOn":{"month":10,"year":2018}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cA Single arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax \u2013TF-ADC) in Previously Treated Recurrent or Metastatic Cervical Cancer\u201d ","startedOn":{"month":10,"year":2018}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cA Phase II Study of MK-3475 (Pembrolizumab) (NSC #776864) +Epacadostat (NSC #766086) in Recurrent Clear Cell Carcinoma of the Ovary\u201d ","startedOn":{"month":10,"year":2018}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201c A Randomized Phase II Study Comparing Single Agent Olaparib, Single Agent Cediranib, and the Combination of Cediranib\/ Olaparib in Women with Recurrent, Persistent, or Metastatic Endometrial Cancer\u201d","startedOn":{"month":10,"year":2018}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cA Phase III, Multicenter, Randomized, Study of Atezolizumab versus Placebo Administered in Combination with Paclitaxel, Carboplatin, and Bevacizumab to Patients with Newly Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Can","startedOn":{"month":10,"year":2018}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cA Randomized Phase II Trial of Everolimus and Letrozole or Hormonal Therapy (Tamoxifen\/ Medroxyprogesterone Acetate) in Women with Advanced Persistent or Recurrent Endometrial Carcinoma\u201d ","startedOn":{"month":10,"year":2018}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cA Randomized Trial of Pelvic Irradiation With or Without Concurrent Weekly Cisplatin In Patients With Pelvic- Only Recurrence Of Carcinoma Of The Uterine Corpus)\u201d","startedOn":{"month":10,"year":2018}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cA Randomized Phase II Trial of Paclitaxel and Carboplatin vs. Bleomycin, Etoposide, and Cisplatin for Newly Diagnosed Advanced Stage and Recurrent Chemonaive Sex Cord-Stromal Tumors of the Ovary\u201d ","startedOn":{"month":10,"year":2018}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cRandomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I\/IIA Cervical Cancer Treated with Initial  Radical Hysterectomy and Pelvic Lymphadenectomy\u201d ","startedOn":{"month":10,"year":2018}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cPhase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High Risk Patients with Early Stage Cervical Carcinoma Following Radical Hysterectomy\u201d ","startedOn":{"month":10,"year":2018}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cA Phase I\/II study of the Combination of Olaparib and Tremelimumab, in BRCA1 and BRCA2 Mutation Carriers with Recurrent Ovarian Cancer\u201d ","startedOn":{"month":10,"year":2018}},{"endedOn":{"month":3,"year":2018},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cEvaluation of the Benefits and Risks in Maintenance Renal Transplant Recipients Following Conversion to Nulojix \u00ae (Belatacept)- based Immunosuppression\u201d","startedOn":{"month":11,"year":2016}},{"endedOn":{"month":3,"year":2018},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cInternational Randomized Trail to Evaluate the Effectiveness of The Portable Organ Care System (OCS\u2122) Liver Device for Preserving and Assessing Donor Livers for Transplantation (OCS Liver PROTECT Trial)\u201d","startedOn":{"month":11,"year":2016}},{"endedOn":{"month":3,"year":2018},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cProtective Effects of Propranolol in Adults Following Major Burn Injury: A Phase IIa\/b Safety and Efficacy Trial\u201d","startedOn":{"month":11,"year":2016}},{"endedOn":{"month":3,"year":2018},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cA Multicenter, multinational, randomized, controlled, assessor blinded study performed in subjects with thermal burns to evaluate the efficacy and safety of NexoBrid compared to Gel Vehicle and compared to Standard of Care\u201d","startedOn":{"month":11,"year":2016}},{"endedOn":{"month":3,"year":2018},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cUse of Rotational Thromboelastometry (ROTEM) to guide thrombolysis therapy in trauma and burn patients\u201d","startedOn":{"month":11,"year":2016}},{"endedOn":{"month":3,"year":2018},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cSigh Ventilation to Increase Ventilator-Free Days in Victims of Trauma at Risk for the Acute Respiratory Distress Syndrome\u201d ","startedOn":{"month":11,"year":2016}},{"endedOn":{"month":3,"year":2018},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cThe RE-ENERGIZE Study: Randomized trial of Enteral Glutamine to minimize thermal injury\u201d","startedOn":{"month":11,"year":2016}},{"endedOn":{"month":3,"year":2018},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cProspective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot \u00ae Polysaccharide Hemostatic System\u201d","startedOn":{"month":11,"year":2016}},{"endedOn":{"month":3,"year":2018},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cComparative Analysis of Chronobiological Changes in Burn, Trauma, and Traumatic Brain Injury\u201d ","startedOn":{"month":11,"year":2016}},{"endedOn":{"month":3,"year":2018},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cBiomarkers following Burn Injury\u201d","startedOn":{"month":11,"year":2016}},{"endedOn":{"month":3,"year":2018},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cPrehospital Air Medical Plasma (PAMPer) Phase III Multicenter, Prospective, Randomized, Open-label, Interventional Trail\u201d","startedOn":{"month":11,"year":2016}},{"endedOn":{"month":8,"year":2017},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cPrehospital Tranexamic Acid Use for Traumatic Brain Injury\u201d","startedOn":{"month":11,"year":2016}},{"endedOn":{"month":3,"year":2018},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cA Phase IV, multicenter, prospective, randomized, controlled clinical study to compare the IrriSept System versus Standard of Care (SoC) on the prevalence of Surgical Site Infection (SSI) in patients with abdominal trauma or acute surgical abdomen\u201d","startedOn":{"month":11,"year":2016}},{"endedOn":{"month":3,"year":2018},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cTegaderm CHG Port Dressing Patient and Clinician Satisfaction Study: A Prospective, Observation Study of the Satisfaction of a new Port Dressing System for Implanted Port Infusion Therapy\u201d","startedOn":{"month":11,"year":2016}},{"endedOn":{"month":3,"year":2018},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cA Randomized, Multi-site, Parallel-group, Rater-blind Study Comparing Response of Aripiprazole Once Monthly and Standard of Care Oral Antipsychotics in Non-Adherent Outpatients with Schizophrenia Identified using the Brief Adherence Rating Scale\u201d","startedOn":{"month":7,"year":2017}},{"endedOn":{"month":3,"year":2018},"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cSchizophrenia Research Database\u201d","startedOn":{"month":7,"year":2017}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cTransforming Research and Clinical Knowledge in Traumatic Brain Injury II (TRACK-TBI II)\u201d ","startedOn":{"month":10,"year":2015}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cMuscarinic and Sj\u00f6grens Associated Antibodies in Postural Orthostatic Tachycardia Syndrome\u201d ","startedOn":{"month":4,"year":2016}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cFieldable Multiplex Test for TBI Assessment\u201d","startedOn":{"month":10,"year":2015}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cComparative Effectiveness of Early Integrated Telehealth versus In-Person Palliative Care for Patients with Advance Lung Cancer\u201d ","startedOn":{"month":3,"year":2018}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cImproving Disparities in Advanced Care Planning for Older African American Adults\u201d","startedOn":{"month":3,"year":2018}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cExpand Treatment and Detect, Navigate, Coordinate, Educate to Eliminate HCV (ERADICATE-HCV)\u201d ","startedOn":{"month":3,"year":2018}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"description":"An Open Label Phase IIA Study Evaluating Trastuzumab\/Pertuzumab, Erlotinib, ,Vermurafenib\/Cobimetinib, Vismodegib, Alectinib, and Atezolizumab in Patients Who Have Advance Solid Tumors with Mutations or Gene Expression Abnormalities Predictive of Response to One of these Agents\" ","title":"\" ML28897 (PRO-02)\"","startedOn":{"month":3,"year":2019}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cMolecular Analysis for Therapy Choice (MATCH)\u201d","startedOn":{"month":10,"year":2018}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"title":"\u201cUse of a Clinical Trial Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)\u201d","startedOn":{"month":10,"year":2018}},{"members":[{"entityUrn":"urn:li:fs_salesProfile:(ACwAACMlRxQBJ4FbOp0LmTMPjLHjK-VUYGdjLS0,NAME_SEARCH,EQz8)"}],"description":"\"AstraZeneca AB D081RC00001: A Phase III Randomised, Double-Blind, Placebo-Controlled, Multicentre Study of Durvalumab in Combination with Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib in Newly Diagnosed Advanced Ovarian Cancer Patients (DUO-O)\"","title":"DUO-O","startedOn":{"month":3,"year":2019}}],"contactInfo":{"emails":[{"dataSource":"LINKEDIN","emailAddress":"christydraper@my.unt.edu"}],"$anti_abuse_annotations":[{"attributeId":21,"entityId":1,"sourceUrn":"urn:li:member:589645588"}],"primaryEmail":"christydraper@my.unt.edu"},"industry":"Hospitals and Health Care","educations":[{"school":"urn:li:fs_salesSchool:6464","fieldsOfStudy":["Medical Anthropology"],"schoolName":"University of North Texas","schoolUrn":"urn:li:fs_salesSchool:6464","eduId":530876820}],"skills":[{"numOfEndorsement":5,"name":"Clinical Trials & Human Subjects Research"},{"numOfEndorsement":2,"name":"Clinical Site Level Management"},{"numOfEndorsement":1,"name":"Servant Leadership"},{"numOfEndorsement":4,"name":"Good Clinical Practice (GCP)"},{"numOfEndorsement":2,"name":"ICH"},{"numOfEndorsement":2,"name":"Good Laboratory Practice (GLP)"},{"numOfEndorsement":1,"name":"Phlebotomy"},{"numOfEndorsement":1,"name":"Database Design"},{"numOfEndorsement":1,"name":"Advanced Cardiac Life Support (ACLS)"},{"numOfEndorsement":1,"name":"Pediatric Advanced Life Support (PALS)"},{"numOfEndorsement":3,"name":"Public Health"},{"numOfEndorsement":4,"name":"Clinical Research"},{"numOfEndorsement":2,"name":"Electronic Data Capture (EDC)"},{"numOfEndorsement":1,"name":"Vendor Management"},{"numOfEndorsement":0,"name":"Visio"},{"numOfEndorsement":1,"name":"Microsoft Excel"},{"numOfEndorsement":2,"name":"Epic Systems"},{"numOfEndorsement":1,"name":"Meditech"},{"numOfEndorsement":0,"name":"ArcGIS"},{"numOfEndorsement":1,"name":"Microsoft PowerPoint"},{"numOfEndorsement":1,"name":"Microsoft Publisher"},{"numOfEndorsement":2,"name":"Laboratory Information Management System (LIMS)"},{"numOfEndorsement":4,"name":"Project Coordination & Management"},{"numOfEndorsement":1,"name":"Process Building & Improvement"},{"numOfEndorsement":1,"name":"SOP development & writing"},{"numOfEndorsement":2,"name":"Investigational Medical Devices"},{"numOfEndorsement":2,"name":"Regulatory Affairs & Compliance"},{"numOfEndorsement":2,"name":"Cross Functional Team Building"},{"numOfEndorsement":1,"name":"CTA, SOA, Subcontract Coordination"},{"numOfEndorsement":0,"name":"CTMS & Masterfile management"},{"numOfEndorsement":2,"name":"Quality Assurance & Integrity Auditing"},{"numOfEndorsement":2,"name":"Qualitative & Quantitative Research Methodologies"},{"numOfEndorsement":0,"name":"Grant Coordination"},{"numOfEndorsement":0,"name":"Biobanking, cryopreservation techniques, specimen management"},{"numOfEndorsement":1,"name":"Tissue Procurement & Processing "},{"numOfEndorsement":1,"name":"Advanced Trauma Life Support (ATLS)"},{"numOfEndorsement":1,"name":"ADLS (Advanced Disaster Life Support)"},{"numOfEndorsement":1,"name":"BLS Instructor"},{"numOfEndorsement":1,"name":"Phlebotomy Instructor"},{"numOfEndorsement":2,"name":"Neuropsychological Testing"},{"numOfEndorsement":0,"name":"DSM-IV SCID-RV"},{"numOfEndorsement":1,"name":"Protocol review & submission"},{"numOfEndorsement":1,"name":"ICF & HIPAA Form Creation"},{"numOfEndorsement":1,"name":"Investigational Product Supply, Accountability, Tracking, Dispensation"},{"numOfEndorsement":1,"name":"Institutional Review Board (IRB)"},{"numOfEndorsement":2,"name":"CRF design"},{"numOfEndorsement":1,"name":"UNOS DonorNET"},{"numOfEndorsement":1,"name":"CITI"},{"numOfEndorsement":1,"name":"IATA"},{"numOfEndorsement":2,"name":"ECG Interpretation"}],"pronoun":"She\/Her","numOfConnections":183,"patents":[],"headline":"Founder\/Executive Director at Optimum Clinical Research Group","courses":[],"certifications":[{"name":"EMT-I"},{"authority":"American Heart Association","name":"ACLS - Advanced Cardiovascular Life Support","company":"urn:li:fs_salesCompany:157306","companyUrn":"urn:li:fs_salesCompany:157306"},{"authority":"American Heart Association","name":"PALS-Pediatric Advanced Life Support","company":"urn:li:fs_salesCompany:157306","companyUrn":"urn:li:fs_salesCompany:157306"},{"authority":"NATIONAL DISASTER LIFE SUPPORT FOUNDATION, INC.","name":"ADLS - Advanced Disaster Life Support","company":"urn:li:fs_salesCompany:8713272","companyUrn":"urn:li:fs_salesCompany:8713272"},{"authority":"NATIONAL DISASTER LIFE SUPPORT FOUNDATION, INC.","name":"BDLS - Basic Disaster Life Support","company":"urn:li:fs_salesCompany:8713272","companyUrn":"urn:li:fs_salesCompany:8713272"},{"authority":"American Heart Association","name":"BLS-Instructor","company":"urn:li:fs_salesCompany:157306","companyUrn":"urn:li:fs_salesCompany:157306"},{"authority":"NPCE - National Phlebotomy Continuing Education Organization","name":"Phlebotomy-Instructor","company":"urn:li:fs_salesCompany:2596884","companyUrn":"urn:li:fs_salesCompany:2596884"},{"authority":"American College of Surgeons","name":"ATLS - Advanced Trauma Life Support","company":"urn:li:fs_salesCompany:25304","companyUrn":"urn:li:fs_salesCompany:25304"}],"memberBadges":{"premium":false,"openLink":false,"jobSeeker":false},"flagshipProfileUrl":"https:\/\/www.linkedin.com\/in\/christy-draper-research","organizations":[{"name":"American Association of Tissue Banks","position":"Qualified Member since 2014","startedOn":{"year":2014}},{"name":"American Heart Association","position":"Instructor","startedOn":{"month":8,"year":2016}},{"name":"National Disaster Life Support Foundation"},{"name":"Society for Medical Anthropology"},{"name":"The Society of Clinical Research Associates (SoCRA)","position":"Member"}],"location":"Dallas-Fort Worth Metroplex","publications":[],"positions":null,"posts":[{"createdAt":1715454300000,"insightId":"2698dab4-56d8-46cd-ba3b-f0a0c7825a6e","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7192371794706587648,7195136994497187840)","threadUrn":"urn:li:activity:7192371794706587648","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[],"text":"Wade Howell thank you, I appreciate you!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7192371794706587648"}}},{"createdAt":1715454300000,"insightId":"bdd430de-0f42-4e56-8213-b9c08ac826d4","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7192371794706587648,7195136893422903296)","threadUrn":"urn:li:activity:7192371794706587648","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":16,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:295055505"}}}],"text":"Christina Howard thank you so much!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7192371794706587648"}}},{"createdAt":1714869540000,"insightId":"f45347e0-d4b0-4aa2-a9d7-4989b549f7ca","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7192371794706587648,7192684421630644225)","threadUrn":"urn:li:activity:7192371794706587648","reactionsCount":0,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":15,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:978237550"}}}],"text":"Samantha Galvan Thank you!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7192371794706587648"}}},{"createdAt":1714837320000,"insightId":"58ed6f02-402b-4555-b45f-feb6b9f798a4","activityUnion":{"commentActivity":{"socialMetadata":{"reactionTypeCounts":[{"type":"LIKE","count":1}],"entityUrn":"urn:li:fs_salesSocialMetadata:urn:li:comment:(activity:7192371794706587648,7192549154206703618)","threadUrn":"urn:li:activity:7192371794706587648","reactionsCount":1,"commentsCount":0,"canComment":true},"commentary":{"attributes":[{"start":0,"length":10,"value":{"com.linkedin.common.MemberAttributedEntity":{"member":"urn:li:member:711372306"}}}],"text":"Jack Staub Thank you!"},"activityUrl":"https:\/\/www.linkedin.com\/feed\/sales-navigator\/urn:li:activity:7192371794706587648"}}}]}